Marks M J, Stitzel J A, Collins A C
J Pharmacol Exp Ther. 1986 Nov;239(2):358-64.
Mice of two inbred strains, DBA and C3H, were infused i.v. with saline, or 2, 4 or 6 mg/kg/hr of nicotine for 10 days. Two hours after termination of infusion the mice were challenged with one of several nicotine doses and the effects on respiration rate, Y-maze activity and rears, acoustic startle response, heart rate and body temperature were measured. Saline-infused C3H mice were less responsive than were DBA mice for all these tests with the exception of the acoustic startle response test. Nicotine-treated DBA mice developed a dose-related tolerance for most measures, whereas C3H mice did not appear to develop tolerance to any measure until the infusion dose reached 4 mg/kg/hr. The two mouse strains did not differ in the number of [3H] nicotine binding sites in six brain regions, and chronic nicotine treatment elicited similar changes in the binding of this ligand in the two strains. C3H mice had greater concentrations of alpha-[125I] BTX binding in hippocampus, midbrain and hypothalamus than did DBA mice. Chronic nicotine treatment resulted in an identical increase in bungarotoxin binding in the two mouse strains such that the initial strain differences were maintained. These results indicate that a threshold in drug response must be surpassed before a mouse develops tolerance to nicotine. In addition, mechanisms other than differences in receptor numbers must be invoked to explain differences in response to nicotine.
给两个近交系小鼠DBA和C3H静脉注射生理盐水,或分别以2、4或6毫克/千克/小时的剂量注射尼古丁,持续10天。在注射结束两小时后,用几种尼古丁剂量之一对小鼠进行刺激,并测量其对呼吸频率、Y迷宫活动和竖毛反应、听觉惊吓反应、心率和体温的影响。除听觉惊吓反应测试外,在所有这些测试中,注射生理盐水的C3H小鼠比DBA小鼠反应性更低。尼古丁处理的DBA小鼠对大多数指标产生了剂量相关的耐受性,而C3H小鼠在注射剂量达到4毫克/千克/小时之前,似乎对任何指标都没有产生耐受性。这两个小鼠品系在六个脑区的[3H]尼古丁结合位点数量上没有差异,慢性尼古丁处理在这两个品系中引起了该配体结合的相似变化。C3H小鼠海马、中脑和下丘脑的α-[125I]银环蛇毒素结合浓度高于DBA小鼠。慢性尼古丁处理导致这两个小鼠品系的银环蛇毒素结合出现相同程度的增加,从而保持了最初品系间的差异。这些结果表明,小鼠在对尼古丁产生耐受性之前,必须超过药物反应的阈值。此外,必须引入受体数量差异以外的机制来解释对尼古丁反应的差异。